Clínica de Marly S.A. (BVC:MARLY)
Colombia · Delayed Price · Currency is COP 8,500.00
0.00 (0.00%)
At close: Jul 31, 2026
Clínica de Marly Financials Overview
Financials in millions COP. Fiscal year is January - December.
Millions COP. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 442,007 | 435,862 | 413,169 | 362,905 | 321,343 | 278,599 |
Revenue Growth | 4.67% | 5.49% | 13.85% | 12.93% | 15.34% | 32.81% |
Gross Profit Gross Profit Growth | 163,773 | 161,860 | 156,187 | 130,913 | 112,935 | 100,234 |
Operating Income Operating Income Growth | 106,092 | 105,989 | 104,100 | 82,965 | 69,294 | 63,678 |
Net Income Net Income Growth | 89,820 | 87,435 | 87,735 | 64,681 | 54,581 | 48,974 |
Earnings Per Share EPS Growth | - | - | - | 6057.41 | 5111.57 | 4586.50 |
EPS Growth | - | - | - | 18.50% | 11.45% | 78.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 283,028 | 280,972 | 223,606 | 147,660 | 101,319 | 107,173 |
Total Debt Total Debt Growth | 2,730 | 2,984 | 6,691 | 13,304 | 22,317 | 32,248 |
Net Cash (Debt) Net Cash Growth | 280,299 | 277,988 | 216,915 | 134,356 | 79,003 | 74,925 |
Net Cash Growth | 21.34% | 28.16% | 61.45% | 70.06% | 5.44% | 86.31% |
Net Cash Per Share Net Cash Per Share Growth | - | - | - | 12582.56 | 7398.66 | 7016.82 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 37,502 | 54,740 | 9,006 | 32,185 | 46,123 | 32,088 |
Capital Expenditures CapEx Growth | -20,753 | -23,476 | -9,429 | -8,885 | -18,628 | -15,583 |
Free Cash Flow Free Cash Flow Growth | 16,748 | 31,264 | -422.9 | 23,300 | 27,495 | 16,504 |
Free Cash Flow Growth | - | - | - | -15.26% | 66.59% | -26.75% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 37.05% | 37.14% | 37.80% | 36.07% | 35.14% | 35.98% |
Operating Margin | 24.00% | 24.32% | 25.20% | 22.86% | 21.56% | 22.86% |
Pretax Margin | 29.71% | 29.46% | 30.90% | 26.26% | 25.50% | 25.22% |
Profit Margin | 20.32% | 20.06% | 21.23% | 17.82% | 16.98% | 17.58% |
FCF Margin | 3.79% | 7.17% | -0.10% | 6.42% | 8.56% | 5.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1596.000 | - | 1596.000 | 1200.000 | 696.000 | 564.000 |
Dividend Per Share Growth | 15.40% | - | 33.00% | 72.41% | 23.40% | - |
Dividend Yield | 18.78% | - | 25.67% | 22.08% | 13.67% | 23.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 1.01 | 1.04 | 1.03 | 1.40 | 1.66 | 1.40 |
P/FCF Ratio | 5.42 | 2.90 | - | 3.90 | 3.30 | 4.14 |
PS Ratio | 0.21 | 0.21 | 0.22 | 0.25 | 0.28 | 0.25 |